Dysregulation of monocytic nuclear factor-κB by oxidized low-density lipoprotein

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 10, 1997, Pages 1901-1909

  Brand, Korbinian ^a   Eisele, Tamara ^a   Kreusel, Ursula ^a   Page, Michael ^a   Page, Sharon ^a   Haas, Monika ^a   Gerling, Astrid ^b   Kaltschmidt, Christian ^c   Neumann, Franz Josef ^a   Mackman, Nigel ^d   Baeuerle, Patrick A ^e   Walli, Autar K ^b   Neumeier, Dieter ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e AMGEN INC   (United States)

Author keywords

I B ; Macrophages; Monocytes; Nuclear factor B; Oxidized LDL; Reactive oxygen intermediates

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MONOCYTE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 17344373827     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.10.1901     Document Type: Article

References (15)

1. Lenardo MJ, Baltimore D. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 1989;58:227-229.
2. Baeuerle PA. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim Biophys Acta. 1991;1072:63-80.
3. Grilli MJ, Chiu JS, Lenardo MJ. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol. 1993;143:1-62.
4. Thanos D, Maniatis T. NF-κB: a lesson in family values. Cell. 1995;80:529-532.
5. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol. 1994;12:141-179.
6. Cheng QC, Cant A, Moll T, Hofer-Warbinek R, Wagner E, Birnstiel ML, Bach FH, de Martin R. NF-κB subunit-specific regulation of the IκB-α promoter. J Biol Chem. 1994;269:13551-13557.
7. Müller JM, Ziegler-Heitbrock HWL, Baeuerle PA. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology. 1993;187:233-256.
8. Collins T. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest. 1993;68:499-508.
9. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circulation. 1995;91:2488-2496.
10. Brand K, Page S, Walli AK, Neumeier D, Baeuerle PA. Role of NF-kappa B in atherogenesis. Exp Physiol. 1997;82:297-304.
11. Brand K, Page S, Rogler G, Bartsch A, Brandi R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996;97:1715-1722.
12. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
13. Barath P, Fishbein MC, Lao J, Bernson J, Helfaut RH, Forrester JS. Tumor necrosis factor gene expression in human vascular smooth muscle cells detected by in vitro hybridization. Am J Pathol. 1990;137:503-509.
14. Hiscott J, Marois J, Garoufalis J, D'Addarion M, Roulston A, Kwan I, Pepin N, Lacoste J, Nguyen H, Bensi G, Fenton M. Characterization of a functional NF-kappa B site in the human interleukin-1β promoter: evidence for a positive autoregulatory loop. Mol Cell Biol. 1993;13:6231-6240.
15. Terkeltaub R, Banka CL, Solan J, Santoro D, Brand K, Curtiss LK. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler Thromb. 1994;14:47-53.